This invention provides compounds of Formula I which are PAFR antagonists: I and the pharmaceutically acceptable salts thereof. The compounds are useful for treating PAF-mediated disorders, and can be used in methods for treating atherosclerosis and preve
-
Page/Page column 56
(2010/05/14)
More Articles about upstream products of 1225211-50-6